Revenue grew 6.8% and operating profit rose 11.9% year-over-year, led by strong North American demand and cost controls. Strategic exits and global R&D reorganization were implemented, while full-year guidance remains unchanged.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.